Advisory Board August 6, 2024

GLP-1 drugs are used to treat diabetes and obesity, but new studies suggest that the drugs could also be used in other ways, such as helping smokers quit and protecting the brain against Alzheimer’s.

Resource library: Weight management and obesity care

GLP-1 drugs could help with smoking cessation

In a new study published in the Annals of Internal Medicine, researchers found that patients with type 2 diabetes and tobacco use disorder (TUD) who used the GLP-1 drug semaglutide, also known as Ozempic and Wegovy, were less likely to need medical care for TUD than those who used other diabetes drugs.

For the study, researchers emulated seven target trials among 222,942 eligible patients with type 2 diabetes and TUD. The researchers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Clinical Trials, Patient / Consumer, Pharma / Biotech, Provider, Trends
Navigating Complex Regulatory Landscapes in the Biopharmaceutical Industry
How Life Sciences Can Drive Innovation And Sustainability In Returns Management
10X Genomics at JPM: New Products, New Sales Team, New Markets
Enhancing Target Screening with CRISPR Libraries: Revolutionizing Drug Discovery and Functional Genomics
Daiichi Sankyo Announces New CEO

Share This Article